Medical researchers typically play the long game, spending years (and years and years) exploring an idea that could move ...

Please provide your email address to receive an email when new articles are posted on . Clozapine and second-generation long-acting formulations of certain antipsychotics decreased risk for ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that 1 ...

Relapses in a common form of leukemia may be preventable following new research that has identified how the cancer develops resistance to first line treatments. Relapses in a common form of leukemia ...

A large meta-analysis sheds light on the best antipsychotic maintenance strategy to prevent relapse in clinically-stable schizophrenia — with some unexpected results that have potential implications ...

The authors reviewed the literature to identify high-quality studies (observational and controlled) of ANCA-associated vasculitis that included a predetermined target dose of steroids at the end of ...

Recovery from addiction is a challenging journey, filled with both triumphs and setbacks. For individuals seeking long-term sobriety, relapse can be a disheartening reality. However, recent findings ...

Neuroblastoma, a cancer that forms in immature nerve cells, most commonly occurs in young children under the age of five. A high-risk neuroblastoma (HRNB) diagnosis often warrants a three phase ...

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years. A personalized cancer vaccine has been shown to help prevent future ...

Drug addiction is a chronic, often relapsing disorder that affects millions of people worldwide. Despite successful treatment, many individuals struggle to maintain sobriety and may relapse.

Relapses in a common form of leukemia may be preventable following new research which has identified how the cancer develops resistance to first line treatments. New research published in iScience by ...